ArticleCancer research2010

Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

Xiuwei H Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.